Efficacy and Safety of Azilsartan Compared to Olmesartan Medoxomil in Chinese Participants With Grade I or II Essential Hypertension
Condition: Essential HypertensionInterventions: Drug: azilsartan; Drug: Olmesartan medoxomilSponsor: Jiangsu HengRui Medicine Co., Ltd.Recruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 30, 2015 Category: Research Source Type: clinical trials
Lowering Blood Pressure in Primary Care in Vienna
Condition: HypertensionIntervention: Drug: Olmesartan medoxomil, amlodipine, hydrochlorothiazideSponsors: Wilhelminenspital Vienna; Association for the Promotion of Research in Atherosclerosis, Thrombosis and Vascular Biology ; Ludwig Boltzmann Foundation for Cardiovascular ResearchRecruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 16, 2015 Category: Research Source Type: clinical trials
Lowering Blood Pressure in Primary Care in Vienna
Condition: HypertensionIntervention: Drug: Olmesartan medoxomil, amlodipine, hydrochlorothiazideSponsors: Wilhelminenspital Vienna; Association for the Promotion of Research in Atherosclerosis, Thrombosis and Vascular Biology ; Ludwig Boltzmann Foundation for Cardiovascular ResearchNot yet recruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 16, 2015 Category: Research Source Type: clinical trials